Celeste A. Clark's most recent trade in Hain Celestial Group Inc was a trade of 83,000 Common Stock done at an average price of $1.8 . Disclosure was reported to the exchange on May 13, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Hain Celestial Group Inc | Celeste A. Clark | Director | Purchase of securities on an exchange or from another person at price $ 1.79 per share. | 13 May 2025 | 83,000 | 83,000 (0%) | 0% | 1.8 | 148,960 | Common Stock |
Darling Ingredients Inc | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 4,549 | 16,193 (0%) | 0% | 0 | Common Stock | |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 3,728 | 14,108 | - | - | Common Stock Units | |
Hain Celestial Group Inc | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2024 | 19,474 | 87,992 (0%) | 0% | 0 | Common Stock | |
Prestige Consumer Healthca... | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2024 | 2,202 | 11,436 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
Darling Ingredients Inc | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 3,369 | 11,644 (0%) | 0% | 0 | Common Stock | |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 4,046 | 10,106 | - | - | Common Stock Units | |
Kellogg Co | A. Clark Celeste | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 27,600 | 27,600 | - | - | Stock Option | |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 476 | 37,301 | - | - | Phantom Stock Units | |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2023 | 573 | 36,541 | - | - | Phantom Stock Units | |
Prestige Consumer Healthca... | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 2,295 | 9,234 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2023 | 549 | 35,667 | - | - | Phantom Stock Units | |
Darling Ingredients Inc | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 2,571 | 8,222 (0%) | 0% | 0 | Common Stock | |
Darling Ingredients Inc | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 61.02 per share. | 09 May 2023 | 53 | 8,275 (0%) | 0% | 61.0 | 3,234 | Common Stock |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2023 | 5,919 | 5,919 | - | - | Common Stock Units | |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 627 | 34,857 | - | - | Phantom Stock Units | |
Darling Ingredients Inc | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 61.01 per share. | 03 Jan 2023 | 1,557 | 5,651 (0%) | 0% | 61.0 | 94,993 | Common Stock |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 567 | 34,011 | - | - | Phantom Stock Units | |
Hain Celestial Group Inc | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 11,930 | 53,420 (0%) | 0% | 0 | Common Stock | |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 582 | 33,231 | - | - | Phantom Stock Units | |
Prestige Consumer Healthca... | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2022 | 2,495 | 6,939 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 587 | 32,426 | - | - | Phantom Stock Units | |
Darling Ingredients Inc | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 1,817 | 4,094 (0%) | 0% | 0 | Common Stock | |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 5,384 | 31,663 | - | - | Phantom Stock Units | |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 631 | 26,279 | - | - | Phantom Stock Units | |
Darling Ingredients Inc | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 69.84 per share. | 03 Jan 2022 | 1,360 | 2,277 (0%) | 0% | 69.8 | 94,982 | Common Stock |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 130 | 25,521 | - | - | Phantom Stock Units | |
Hain Celestial Group Inc | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 5,187 | 41,490 (0%) | 0% | 0 | Common Stock | |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 132 | 25,284 | - | - | Phantom Stock Units | |
Prestige Consumer Healthca... | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 2,808 | 4,444 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 137 | 25,036 | - | - | Phantom Stock Units | |
Prestige Consumer Healthca... | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 1,636 | 1,636 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 3,993 | 24,845 | - | - | Phantom Stock Units | |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 157 | 20,852 | - | - | Phantom Stock Units | |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 1,018 | 20,639 | - | - | Phantom Stock Units | |
Hain Celestial Group Inc | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Nov 2020 | 6,232 | 36,303 (0%) | 0% | 0 | Common Stock | |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 1,644 | 19,551 | - | - | Phantom Stock Units | |
Wells Fargo & Co. | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 1,544 | 17,832 | - | - | Phantom Stock Units |